Colin Hill Selected Research

Bovine Mastitis

1/2022	Emulsion-Based Postbiotic Formulation Is Comparable to Viable Cells in Eliciting a Localized Immune Response in Dairy Cows With Chronic Mastitis.
3/2021	Bio-Engineered Nisin with Increased Anti-Staphylococcus and Selectively Reduced Anti-Lactococcus Activity for Treatment of Bovine Mastitis.
9/2019	Non-antibiotic microbial solutions for bovine mastitis - live biotherapeutics, bacteriophage, and phage lysins.
1/2019	A Live Bio-Therapeutic for Mastitis, Containing Lactococcus lactis DPC3147 With Comparable Efficacy to Antibiotic Treatment.
1/2016	In Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus Biofilms.
1/2015	A bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermedius.
5/2010	Efficacy of a teat dip containing the bacteriocin lacticin 3147 to eliminate Gram-positive pathogens associated with bovine mastitis.
8/2009	Administration of a live culture of Lactococcus lactis DPC 3147 into the bovine mammary gland stimulates the local host immune response, particularly IL-1beta and IL-8 gene expression.
8/2008	Intramammary infusion of a live culture for treatment of bovine mastitis: effect of live lactococci on the mammary immune response.
8/2008	Intramammary infusion of a live culture of Lactococcus lactis for treatment of bovine mastitis: comparison with antibiotic treatment in field trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Colin Hill Research Topics

Disease

43	Infections 07/2022 - 01/2004
10	Mastitis 01/2022 - 11/2004
10	Bovine Mastitis 01/2022 - 08/2008
5	Bacterial Infections (Bacterial Infection) 01/2021 - 07/2010
5	Listeriosis (Listeria Infection) 10/2019 - 11/2003
4	Neoplasms (Cancer) 03/2021 - 12/2005
4	Obesity 01/2020 - 01/2007
4	Dehydration (Water Stress) 01/2020 - 09/2000
3	Ulcerative Colitis 06/2020 - 05/2009
3	Inflammation (Inflammations) 01/2020 - 01/2016
3	Communicable Diseases (Infectious Diseases) 09/2017 - 11/2003
3	Intestinal Diseases (Diseases, Intestinal) 11/2016 - 04/2009
3	Paratuberculosis (Johne's Disease) 11/2010 - 11/2002
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 03/2021
2	Adenocarcinoma 01/2022 - 03/2021
2	Wounds and Injuries (Trauma) 06/2020 - 04/2012
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2018 - 01/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018 - 05/2009
2	Crohn Disease (Crohn's Disease) 01/2018 - 05/2009
2	Weight Gain 05/2014 - 01/2014
2	Diarrhea 01/2014 - 06/2013
2	Autolysis 08/2009 - 03/2004
2	Heart Diseases (Heart Disease) 08/2008 - 01/2007
1	Lung Neoplasms (Lung Cancer) 05/2021
1	Esophagitis 05/2021
1	Cross Infection (Nosocomial Infection) 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Colitis 01/2020
1	Brain Neoplasms (Brain Tumor) 09/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Osteoporosis 01/2017
1	Meningitis 11/2016
1	Metaplasia 01/2016
1	Hyperplasia 01/2016
1	Staphylococcal Infections 01/2016
1	Foodborne Diseases 01/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2015
1	Short Bowel Syndrome 11/2014
1	Liver Diseases (Liver Disease) 11/2014

Drug/Important Bio-Agent (IBA)

23	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 11/2003
22	Bacteriocins (Lantibiotics)IBA 07/2022 - 01/2004
11	NisinIBA 02/2022 - 03/2004
9	Pharmaceutical PreparationsIBA 01/2021 - 11/2003
6	Virulence Factors (Pathogenicity Factors)IBA 01/2022 - 09/2008
4	Proteins (Proteins, Gene)FDA Link 04/2014 - 02/2008
3	nisin AIBA 06/2020 - 02/2013
3	Peptides (Polypeptides)IBA 01/2020 - 04/2009
3	Bile Acids and Salts (Bile Acids)IBA 11/2014 - 01/2014
3	IronIBA 01/2012 - 02/2004
2	EmulsionsIBA 01/2022 - 01/2019
2	Hemolysin Proteins (Hemolysins)IBA 01/2022 - 01/2011
2	Antimicrobial PeptidesIBA 01/2020 - 09/2017
2	Volatile Fatty AcidsIBA 01/2020 - 01/2018
2	Anti-Infective Agents (Microbicides)IBA 01/2020 - 01/2019
2	VaccinesIBA 07/2014 - 02/2013
2	CholesterolIBA 05/2014 - 01/2014
2	Listeria monocytogenes hlyA protein (listeriolysin O)IBA 03/2014 - 01/2011
2	AcidsIBA 01/2014 - 09/2007
2	Mevalonic Acid (Mevalonate)IBA 07/2012 - 11/2008
2	EnzymesIBA 02/2012 - 03/2004
2	lanthionineIBA 03/2011 - 09/2000
2	Sodium Acetate (Sodium Acetate, Anhydrous)FDA LinkGeneric 04/2009 - 08/2004
2	SugarsIBA 08/2008 - 01/2007
2	Aspartame (NutraSweet)IBA 08/2008 - 01/2007
2	SaltsIBA 08/2008 - 01/2007
1	Enterotoxins (Enterotoxin)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	alpha-SynucleinIBA 01/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2020
1	SteroidsIBA 06/2020
1	Infliximab (Remicade)FDA Link 06/2020
1	Lipocalin-2IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Mineral Oil (Liquid Paraffin)FDA LinkGeneric 01/2019
1	Kanamycin FDA Link 01/2019
1	Cephalexin (Cefalexin)FDA LinkGeneric 01/2019
1	Butyrates (Butyrate)IBA 01/2018
1	Coenzyme A (CoA)IBA 01/2018
1	TransferasesIBA 01/2018
1	Acetates (Acetic Acid Esters)FDA Link 01/2018
1	butyryl-coenzyme AIBA 01/2018
1	PrebioticsIBA 01/2017
1	OligosaccharidesIBA 01/2017
1	LuciferasesIBA 01/2017
1	HydrolasesIBA 01/2016
1	Phenobarbital (Luminal)FDA Link 01/2016
1	Peptidoglycan (Murein)IBA 01/2016
1	Artificial SalivaIBA 01/2015
1	Triglycerides (Triacylglycerol)IBA 05/2014
1	choloylglycine hydrolaseIBA 05/2014
1	thuricinIBA 02/2014

Therapy/Procedure

12	Therapeutics 01/2022 - 07/2004
5	Phage Therapy 01/2021 - 01/2012
4	Radiotherapy 01/2022 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2022 - 12/2005
2	Oral Administration 07/2022 - 01/2020
2	Brachytherapy 07/2018 - 01/2018
1	Complementary Therapies (Alternative Medicine) 01/2022